Apollon Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
8,518
-236
| -3% | -$29.9K | 0.02% | 530 |
|
|
2025
Q1 | $1.12M | Buy |
8,754
+96
| +1% | +$12.3K | 0.02% | 480 |
|
|
2024
Q4 | $1.14M | Buy |
8,658
+1,195
| +16% | +$158K | 0.03% | 468 |
|
|
2024
Q3 | $1.09M | Sell |
7,463
-1,539
| -17% | -$224K | 0.03% | 461 |
|
|
2024
Q2 | $1.24M | Sell |
9,002
-175
| -2% | -$24K | 0.04% | 401 |
|
|
2024
Q1 | $1.26M | Buy |
9,177
+926
| +11% | +$127K | 0.04% | 405 |
|
|
2023
Q4 | $1.12M | Sell |
8,251
-295
| -3% | -$40.1K | 0.04% | 415 |
|
|
2023
Q3 | $1.05M | Sell |
8,546
-1,558
| -15% | -$191K | 0.05% | 349 |
|
|
2023
Q2 | $1.28M | Buy |
10,104
+1,029
| +11% | +$131K | 0.06% | 324 |
|
|
2023
Q1 | $1.17M | Sell |
9,075
-1,131
| -11% | -$146K | 0.07% | 288 |
|
|
2022
Q4 | $1.34M | Sell |
10,206
-239
| -2% | -$31.4K | 0.1% | 225 |
|
|
2022
Q3 | $1.22M | Buy |
10,445
+83
| +0.8% | +$9.71K | 0.1% | 214 |
|
|
2022
Q2 | $1.22M | Sell |
10,362
-364
| -3% | -$42.8K | 0.1% | 222 |
|
|
2022
Q1 | $1.4M | Buy |
10,726
+7,249
| +208% | +$945K | 0.1% | 212 |
|
|
2021
Q4 | $530K | Buy |
3,477
+61
| +2% | +$9.3K | 0.04% | 451 |
|
|
2021
Q3 | $552K | Buy |
3,416
+319
| +10% | +$51.5K | 0.08% | 248 |
|
|
2021
Q2 | $507K | Sell |
3,097
-86
| -3% | -$14.1K | 0.09% | 214 |
|
|
2021
Q1 | $479K | Buy |
+3,183
| New | +$479K | 0.09% | 206 |
|
|
2020
Q3 | – | Sell |
-393
| Closed | -$54K | – | 385 |
|
|
2020
Q2 | $54K | Buy |
+393
| New | +$54K | 0.03% | 235 |
|